US Drug Recall Register
Class I · High risk Terminated Initiated Nov 20, 2019 (7 years ago)

Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.

What was recalled

Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-001-05

Recalling firm
AuroMedics Pharma LLC
NDC code
13107-001-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0637-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all